| Patent Number |
Title Of Patent |
Date Issued |
| 7428125 |
Rotating disk storage device and pivot bearing |
September 23, 2008 |
| Embodiments of the invention position accurately an actuator head suspension assembly (AHSA) relative to a magnetic disk without using any positioning jig, as achieved through a simple structure and involving no increase in manufacturing, and to prevent the AHSA from being charge. In |
| 7372669 |
Magnetic disk drive, wiring connection structure and terminal structure |
May 13, 2008 |
| Terminals of a flexible printed circuit board and terminals of a wiring trace in a head suspension assembly are to be connected with each other by soldering without causing a soldering defect. In an embodiment, a terminal structure of a multi-connector in a wiring trace which includes |
| 6952323 |
System and method of constraining vibration in a disk drive unit and motor device |
October 4, 2005 |
| A disk drive unit has a spindle motor for rotating a disk, a magnetic head for processing data, a actuator for seeking the magnetic head with respect to the disk, a voice coil motor for moving the actuator, and a base with an opening and a top cover that seals the opening. A damper is di |
| 5663205 |
Pharmaceutical composition for use in glaucoma treatment |
September 2, 1997 |
| A pharmaceutical composition for use in glaucoma treatment which contains as an active ingredient 5-[1-hydroxy-2-[2-(2-methoxyphenoxyl)ethylamino]ethyl]-2-methylbenzenesulf onamide of the formula: ##STR1## or its acid salt. This agent is free from side effects and stable and has |
| 5652272 |
Ophthalmic preparations for reducing intraocular pressure |
July 29, 1997 |
| The present invention provides an ophthalmic preparation for reducing intraocular pressure comprising 2-[3-dimethyl-amino-2-(2-carboxyethoxy)propionyloxy]-2'-methoxybibenzyl or a salt thereof, which preparation exhibits intraocular pressure reducing activity, without exerting effects |
| 5639773 |
Ocular hypotensive agent |
June 17, 1997 |
| This invention relates to an ocular hypotensive agent which comprises a compound represented by the formula: ##STR1## wherein R.sup.1 represents hydrogen or an optionally substituted hydrocarbon residue that may be bound via a hetero atom; R.sup.2 represents hydrogen or a hydroca |
| 5538974 |
Ophthalmic composition for lowering intraocular pressure |
July 23, 1996 |
| An ophthalmic composition comprising a compound of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each a hydrogen, a halogen, a hydroxyl, a lower alkyl or a lower alkoxy, R.sup.3 and R.sup.4 are each a hydrogen, an optionally substituted lower alkyl, an optionally substituted c |
| 5504087 |
1-phenoxy-2-propanol derivatives useful in treating hypertension and glaucoma |
April 2, 1996 |
| A hypotensive agent and antiglaucoma agent which comprise a compound represented by the following formula: ##STR1## (wherein R.sub.1 is hydrogen, or a lower alkyl or lower alkoxy group; R.sub.2 is an isopropylamino, tert-butylamino, 2-(2-methoxyphenyl)ethyl-1-amino, 4-(2-methoxyp |
